2020 Virtual ESMO Review

 

2020 Virtual ESMO Review
Avatar

2020 ESMO Updates in Lung Cancer: Does 1L Nivolumab–Ipilimumab Boost Unresectable Mesothelioma OS? Did the PACIFIC Trial Demonstrate Durable Benefit With Durvalumab After cCRT in Stage 3 NSCLC?

By 2020 Virtual ESMO Review FEATURING Martin Dietrich
By 2020 Virtual ESMO Review FEATURING Martin Dietrich
616 views
November 4, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
Videos
05:09

2020 ESMO Update on R/R DLBCL: Does AUTO3 + Pembro Induce CRs? What …

2020 Virtual ESMO Review

J. Amengual

20 views
07:49

2020 ESMO Update on R/R cHL: How Effective Is Brentuximab Vedotin?

2020 Virtual ESMO Review

J. Amengual

55 views
06:52

2020 ESMO Update on Non-Hodgkin Lymphomas: Does BETi CC-90010 Lead t…

2020 Virtual ESMO Review

J. Amengual

17 views
07:33

2020 ESMO Update on Targeted Therapy in NSCLC: Does ADAURA Trial Sug…

2020 Virtual ESMO Review

I. Dagogo-Jack

177 views
05:44

2020 ESMO Update on Targeted Therapy in NSCLC: Can We Safely Combine…

2020 Virtual ESMO Review

I. Dagogo-Jack

29 views
06:52

2020 ESMO Update on UC: Does 1L Durvalumab +/- Tremelimumab Improve …

2020 Virtual ESMO Review

M. Bupathi

47 views
08:30

2020 ESMO Update on RCC: Is IO + TKI Option Effective in Advanced Di…

2020 Virtual ESMO Review

M. Bupathi

213 views
07:47

2020 ESMO Update on Advanced UC: Does the Addition of Avelumab 1L Ma…

2020 Virtual ESMO Review

M. Bupathi

74 views
11:16

2020 ESMO Update on ALK+ NSCLC: PFS Data With Lorlatinib vs. Crizoti…

2020 Virtual ESMO Review

I. Dagogo-Jack

233 views
20:42

ESMO 2020 Update on mPC: How Beneficial Is Abiraterone+/-Ipatasertib…

2020 Virtual ESMO Review

T. Barauskas Dorff

85 views
33:00

Will COVID-19 Leave Its Mark on Cancer Care?

Total Health

G. Lopes

1.8K views
08:53

2020 ESMO Updates on Pembrolizumab & Cemiplimab: Can mNSCLC Be Cured…

2020 Virtual ESMO Review

M. Dietrich

599 views
06:15

2020 ESMO First Results from PIONeeR Project on Biomarkers in Advanc…

2020 Virtual ESMO Review

M. Dietrich

515 views
09:56

2020 ESMO Updates in Lung Cancer: Does 1L Nivolumab–Ipilimumab Boost…

2020 Virtual ESMO Review

M. Dietrich

616 views
07:30

2020 ESMO Update on MBC: Is There OS Benefit to Alpelisib + Fulvestr…

2020 Virtual ESMO Review

J. Crozier

121 views
10:12

2020 ESMO Update on MBC: Does the Addition of Tamoxifen to Abemacicl…

2020 Virtual ESMO Review

J. Crozier

523 views
08:19

2020 ESMO Update on Immune Checkpoint Inhibitors in eTNBC: Does the …

2020 Virtual ESMO Review

L. Schwartzberg

379 views
06:06

2020 ESMO Update on CDK 4/6 in Adjuvant HR+, HER2- EBC: Does the Add…

2020 Virtual ESMO Review

L. Schwartzberg

184 views
07:46

2020 ESMO Update on CDK 4/6 in Adjuvant HR+, HER2- EBC: How Does Two…

2020 Virtual ESMO Review

L. Schwartzberg

200 views
13:27

2020 ESMO Update on mPDAC: Does the Addition of Dual Immune Checkpoi…

2020 Virtual ESMO Review

L. Connell

229 views
08:07

2020 ESMO Update on Metastatic Pancreatic Cancer: What Does the Qoli…

2020 Virtual ESMO Review

L. Connell

64 views